Emergence of Q493R mutation in SARS-CoV-2 spike protein during bamlanivimab/etesevimab treatment and resistance to viral clearance

Guigon, A., Faure, E., Lemaire, C., Chopin, M. C., Tinez, C., Assaf, A., … Alidjinou, E. K. (2022, February 1). Emergence of Q493R mutation in SARS-CoV-2 spike protein during bamlanivimab/etesevimab treatment and resistance to viral clearance. Journal of Infection. W.B. Saunders Ltd. https://doi.org/10.1016/j.jinf.2021.08.033